Eli Lilly and Co

NYSE:LLYHealthcareCBOE:SPESGNASDAQ:NQUSLG

$1,240.34−1.33%At closeAt close · Tue 20 Oct · ≈ AED 4,555.15 · Market cap $1.17T · Next earnings Thu 29 Oct · Extended $1,241.06 +0.06%

Ratio	FY2020	FY2021	FY2022	FY2023	FY2024	FY2025	Current · undated	YoY
Gross margin	77.7%	74.2%	76.8%	79.2%	81.3%	83.8%	—	—
Operating margin	29.4%	28.0%	30.3%	31.6%	38.9%	45.6%	45.6%	+0.0 pts
Net margin	25.2%	19.7%	21.9%	15.4%	23.5%	31.7%	31.7%	+0.0 pts
EBITDA margin	36.3%	28.4%	30.3%	25.1%	33.8%	42.9%	—	—
Return on equity	109.8%	62.2%	58.6%	48.6%	74.6%	77.8%	77.8%	+0.0 pts
Return on assets	13.3%	11.4%	12.6%	8.2%	13.5%	18.3%	18.4%	+0.0 pts
Return on capital employed	21.1%	23.5%	26.7%	29.4%	34.8%	38.4%	—	—
Debt / equity	2.9×	1.9×	1.5×	2.3×	2.4×	1.6×	1.6×	+0.0%
Debt / assets	35.6%	34.6%	32.8%	39.4%	42.7%	37.8%	—	—
Interest coverage	20.1×	23.3×	26.1×	22.2×	22.4×	37.3×	—	—
Current ratio	1.4×	1.2×	1.1×	0.9×	1.2×	1.6×	1.6×	+0.0%
Quick ratio	1.1×	1.0×	0.8×	0.7×	0.9×	1.2×	—	—
Cash ratio	0.3×	0.3×	0.1×	0.1×	0.1×	0.2×	0.2×	+0.0%
Asset turnover	0.5×	0.6×	0.6×	0.5×	0.6×	0.6×	—	—
Inventory turnover	1.4×	1.9×	1.5×	1.2×	1.1×	0.8×	—	—
Receivables turnover	3.5×	3.5×	3.3×	3.0×	3.4×	3.2×	—	—
Dividend payout	43.4%	55.3%	56.6%	77.7%	44.2%	26.1%	—	—